Clinical trial
Prospective Study Characterizing Fecal Microbiome Disruptions During and After Receipt of Antimicrobials
NCT03098485 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Study Characterizing Fecal Microbiome Disruptions During and After Receipt of Antimicrobials
- Lead sponsor
- Washington University School of Medicine
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 31, 2017
- Completion date
- August 30, 2022
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anti-bacterial agents, microbiota